Почетна › Рак на бели дробови › Тенеси › Memphis
Клинички испитувања за Рак на бели дробови во Memphis, TN
18 студии за Рак на бели дробови бараат учесници на локации во и околу Memphis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Се регрутираФаза 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Се регрутираФаза 2
- Research Site, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Baptist Memorial Hospital-Memphis, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Baptist Cancer Center, Memphis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Се регрутираФаза 3
- Baptist Cancer Center, Southaven · на 11 милји
- West Cancer Center & Research Institute, Germantown · на 14 милји
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Се регрутираФаза 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Се регрутираФаза 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Се регрутираДобредојдени се здрави волонтери
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Memphis
Испитувања за Рак на бели дробови во други градови
- Houston, TX78 студии
- Boston, MA62 студии
- New York City, NY60 студии
- Los Angeles, CA45 студии
- Arlington, VA41 студија
- Washington, DC41 студија
- Chicago, IL41 студија
- Baltimore, MD40 студии
- Nashville, TN40 студии
- St. Louis, MO39 студии
- Columbus, OH37 студии
- Philadelphia, PA36 студии
Други студии во Memphis
- Рак (сите типови)31 студија
- Рак на бели дробови со не-мали клетки23 студии
- Рак на дојка22 студии
- Српеста анемија18 студии
- Акутна лимфобластна леукемија16 студии
- Акутна миелоидна леукемија15 студии
- Срцева слабост13 студии
- Сарком на меко ткиво11 студии
- Меланом11 студии
- Рак на простата11 студии
- Колоректален карцином11 студии
- Остеосарком10 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.